Cargando…
Bactercline(®)-coated implants: Clinical results up to 1 year after loading from a controlled clinical trial
BACKGROUND: Titanium dioxide exists in three different crystal lattices, anatase, rutile, and brookite. Anatase coating releases, under ultraviolet (UV) irradiation, free radicals such as ·OH, O(2)(-), HO(2)(-), and H(2)O(2). This potent oxidizing power characteristically results in the lysis of bac...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3692162/ https://www.ncbi.nlm.nih.gov/pubmed/23814572 http://dx.doi.org/10.4103/1735-3327.109724 |
_version_ | 1782274584218697728 |
---|---|
author | Carinci, Francesco Grecchi, Emma Bignozzi, Carlo Alberto Murmura, Giovanna Piattelli, Adriano Scarano, Antonio |
author_facet | Carinci, Francesco Grecchi, Emma Bignozzi, Carlo Alberto Murmura, Giovanna Piattelli, Adriano Scarano, Antonio |
author_sort | Carinci, Francesco |
collection | PubMed |
description | BACKGROUND: Titanium dioxide exists in three different crystal lattices, anatase, rutile, and brookite. Anatase coating releases, under ultraviolet (UV) irradiation, free radicals such as ·OH, O(2)(-), HO(2)(-), and H(2)O(2). This potent oxidizing power characteristically results in the lysis of bacteria and other organic substances. The purpose of this study was to evaluate the bone response to implants made of titanium alloy or coated with a new combination of anatase and Bactercline(®) product. MATERIALS AND METHODS: In the period between July 2009 and June 2010, 26 patients (10 females and 16 males; median age 51 ± 11 years, min. 27 years, max. 72 years) were operated and 62 implants were inserted. Lost fixtures and peri-implant bone resorption were considered as predictors of clinical outcomes. Pearson χ(2)-test was used. Prosthesis and implant failures, any complications after loading, and peri-implant marginal bone-level changes were assessed by a masked assessor. All patients were followed up to 1 year after loading. RESULTS: No implant was lost. Average bone resorption around implant was 0.33 mm (both for 25 standard and 37 Bactercline-coated implants), and thus no statistical difference was detected. CONCLUSION: These results shown that no adverse effects on osseo-integration were present. |
format | Online Article Text |
id | pubmed-3692162 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-36921622013-06-28 Bactercline(®)-coated implants: Clinical results up to 1 year after loading from a controlled clinical trial Carinci, Francesco Grecchi, Emma Bignozzi, Carlo Alberto Murmura, Giovanna Piattelli, Adriano Scarano, Antonio Dent Res J (Isfahan) Original Article BACKGROUND: Titanium dioxide exists in three different crystal lattices, anatase, rutile, and brookite. Anatase coating releases, under ultraviolet (UV) irradiation, free radicals such as ·OH, O(2)(-), HO(2)(-), and H(2)O(2). This potent oxidizing power characteristically results in the lysis of bacteria and other organic substances. The purpose of this study was to evaluate the bone response to implants made of titanium alloy or coated with a new combination of anatase and Bactercline(®) product. MATERIALS AND METHODS: In the period between July 2009 and June 2010, 26 patients (10 females and 16 males; median age 51 ± 11 years, min. 27 years, max. 72 years) were operated and 62 implants were inserted. Lost fixtures and peri-implant bone resorption were considered as predictors of clinical outcomes. Pearson χ(2)-test was used. Prosthesis and implant failures, any complications after loading, and peri-implant marginal bone-level changes were assessed by a masked assessor. All patients were followed up to 1 year after loading. RESULTS: No implant was lost. Average bone resorption around implant was 0.33 mm (both for 25 standard and 37 Bactercline-coated implants), and thus no statistical difference was detected. CONCLUSION: These results shown that no adverse effects on osseo-integration were present. Medknow Publications & Media Pvt Ltd 2012-12 /pmc/articles/PMC3692162/ /pubmed/23814572 http://dx.doi.org/10.4103/1735-3327.109724 Text en Copyright: © Dental Research Journal http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Carinci, Francesco Grecchi, Emma Bignozzi, Carlo Alberto Murmura, Giovanna Piattelli, Adriano Scarano, Antonio Bactercline(®)-coated implants: Clinical results up to 1 year after loading from a controlled clinical trial |
title | Bactercline(®)-coated implants: Clinical results up to 1 year after loading from a controlled clinical trial |
title_full | Bactercline(®)-coated implants: Clinical results up to 1 year after loading from a controlled clinical trial |
title_fullStr | Bactercline(®)-coated implants: Clinical results up to 1 year after loading from a controlled clinical trial |
title_full_unstemmed | Bactercline(®)-coated implants: Clinical results up to 1 year after loading from a controlled clinical trial |
title_short | Bactercline(®)-coated implants: Clinical results up to 1 year after loading from a controlled clinical trial |
title_sort | bactercline(®)-coated implants: clinical results up to 1 year after loading from a controlled clinical trial |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3692162/ https://www.ncbi.nlm.nih.gov/pubmed/23814572 http://dx.doi.org/10.4103/1735-3327.109724 |
work_keys_str_mv | AT carincifrancesco bacterclinecoatedimplantsclinicalresultsupto1yearafterloadingfromacontrolledclinicaltrial AT grecchiemma bacterclinecoatedimplantsclinicalresultsupto1yearafterloadingfromacontrolledclinicaltrial AT bignozzicarloalberto bacterclinecoatedimplantsclinicalresultsupto1yearafterloadingfromacontrolledclinicaltrial AT murmuragiovanna bacterclinecoatedimplantsclinicalresultsupto1yearafterloadingfromacontrolledclinicaltrial AT piattelliadriano bacterclinecoatedimplantsclinicalresultsupto1yearafterloadingfromacontrolledclinicaltrial AT scaranoantonio bacterclinecoatedimplantsclinicalresultsupto1yearafterloadingfromacontrolledclinicaltrial |